Disease_1
stringlengths 4
61
| Disease_2
stringlengths 4
61
| Similarity_Score
stringclasses 78
values |
|---|---|---|
Drug-Induced Abnormalities | Microphthalmos | 0.38355214601147614 |
Drug-Induced Abnormalities | Microstomia | 0.3430264696222015 |
Drug-Induced Abnormalities | Severe Teratoid Abnormalities | 0.4373356273919856 |
Drug-Induced Abnormalities | Dental Fluorosis | 0.28232930875488305 |
Drug-Induced Abnormalities | Mouth Abnormalities | 0.38355214601147614 |
Drug-Induced Abnormalities | Mucolipidoses | 0.15364182357778045 |
Drug-Induced Abnormalities | Mucopolysaccharidoses | 0.15364182357778045 |
Drug-Induced Abnormalities | Mucopolysaccharidosis III | 0.12229063423583264 |
Drug-Induced Abnormalities | Mucopolysaccharidosis IV | 0.12229063423583264 |
Drug-Induced Abnormalities | Mucopolysaccharidosis VI | 0.12229063423583264 |
Drug-Induced Abnormalities | Multiple Carboxylase Deficiency | 0.15364182357778045 |
Drug-Induced Abnormalities | Muscular Dystrophies | 0.22612546428933034 |
Drug-Induced Abnormalities | Musculoskeletal Abnormalities | 0.4373356273919856 |
Drug-Induced Abnormalities | Myotonic Dystrophy | 0.18766904849475052 |
Drug-Induced Abnormalities | Myotonia Congenita | 0.18766904849475052 |
Drug-Induced Abnormalities | Nail-Patella Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Neonatal Abstinence Syndrome | 0.22612546428933034 |
Drug-Induced Abnormalities | Multiple Endocrine Neoplasia | 0.18766904849475052 |
Drug-Induced Abnormalities | Hereditary Neoplastic Syndromes | 0.22612546428933034 |
Drug-Induced Abnormalities | Hereditary Nephritis | 0.38355214601147614 |
Drug-Induced Abnormalities | Wilms Tumor | 0.18766904849475052 |
Drug-Induced Abnormalities | Nervous System Malformations | 0.4373356273919856 |
Drug-Induced Abnormalities | Neural Tube Defects | 0.38355214601147614 |
Drug-Induced Abnormalities | Neurofibromatosis 1 | 0.15364182357778045 |
Drug-Induced Abnormalities | Neuronal Ceroid-Lipofuscinoses | 0.18766904849475052 |
Drug-Induced Abnormalities | Hereditary Sensory and Autonomic Neuropathies | 0.38355214601147614 |
Drug-Induced Abnormalities | Niemann-Pick Diseases | 0.09245500931811057 |
Drug-Induced Abnormalities | Noonan Syndrome | 0.3430264696222015 |
Drug-Induced Abnormalities | Oculocerebrorenal Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Olivopontocerebellar Atrophies | 0.15364182357778045 |
Drug-Induced Abnormalities | Ophthalmia Neonatorum | 0.22612546428933034 |
Drug-Induced Abnormalities | Orofaciodigital Syndromes | 0.38355214601147614 |
Drug-Induced Abnormalities | Primary Hypertrophic Osteoarthropathy | 0.22612546428933034 |
Drug-Induced Abnormalities | Osteochondrodysplasias | 0.22612546428933034 |
Drug-Induced Abnormalities | Osteogenesis Imperfecta | 0.22612546428933034 |
Drug-Induced Abnormalities | Papillon-Lefevre Disease | 0.15364182357778045 |
Drug-Induced Abnormalities | Familial Periodic Paralyses | 0.15364182357778045 |
Drug-Induced Abnormalities | Obstetric Paralysis | 0.18766904849475052 |
Drug-Induced Abnormalities | Pelger-Huet Anomaly | 0.22612546428933034 |
Drug-Induced Abnormalities | Familial Mediterranean Fever | 0.18766904849475052 |
Drug-Induced Abnormalities | Persistent Fetal Circulation Syndrome | 0.22612546428933034 |
Drug-Induced Abnormalities | Peutz-Jeghers Syndrome | 0.18766904849475052 |
Drug-Induced Abnormalities | Phenylketonurias | 0.15364182357778045 |
Drug-Induced Abnormalities | Pierre Robin Syndrome | 0.310198271667516 |
Drug-Induced Abnormalities | Platybasia | 0.3430264696222015 |
Drug-Induced Abnormalities | Rothmund-Thomson Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Poland Syndrome | 0.310198271667516 |
Drug-Induced Abnormalities | Adenomatous Polyposis Coli | 0.18766904849475052 |
Drug-Induced Abnormalities | Prader-Willi Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Progeria | 0.18766904849475052 |
Drug-Induced Abnormalities | Prognathism | 0.310198271667516 |
Drug-Induced Abnormalities | Prune Belly Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Pseudohypoaldosteronism | 0.18766904849475052 |
Drug-Induced Abnormalities | Pseudohypoparathyroidism | 0.15364182357778045 |
Drug-Induced Abnormalities | Pseudopseudohypoparathyroidism | 0.12229063423583264 |
Drug-Induced Abnormalities | Pseudoxanthoma Elasticum | 0.38355214601147614 |
Drug-Induced Abnormalities | Inborn Errors Purine-Pyrimidine Metabolism | 0.18766904849475052 |
Drug-Induced Abnormalities | Refsum Disease | 0.3430264696222015 |
Drug-Induced Abnormalities | Newborn Respiratory Distress Syndrome | 0.18766904849475052 |
Drug-Induced Abnormalities | Retinitis Pigmentosa | 0.18766904849475052 |
Drug-Induced Abnormalities | Retinopathy of Prematurity | 0.18766904849475052 |
Drug-Induced Abnormalities | Congenital Rubella Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Rubinstein-Taybi Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Sandhoff Disease | 0.033794500669876215 |
Drug-Induced Abnormalities | Scimitar Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Sclerema Neonatorum | 0.38355214601147614 |
Drug-Induced Abnormalities | Sea-Blue Histiocyte Syndrome | 0.09245500931811057 |
Drug-Induced Abnormalities | Disorders of Sex Development | 0.38355214601147614 |
Drug-Induced Abnormalities | Short Rib-Polydactyly Syndrome | 0.38355214601147614 |
Drug-Induced Abnormalities | Sickle Cell Trait | 0.15364182357778045 |
Drug-Induced Abnormalities | Situs Inversus | 0.4373356273919856 |
Drug-Induced Abnormalities | Skin Abnormalities | 0.4373356273919856 |
Drug-Induced Abnormalities | Genetic Skin Diseases | 0.22612546428933034 |
Drug-Induced Abnormalities | Hereditary Spherocytosis | 0.18766904849475052 |
Drug-Induced Abnormalities | Sphingolipidoses | 0.12229063423583264 |
Drug-Induced Abnormalities | Spinocerebellar Degenerations | 0.18766904849475052 |
Drug-Induced Abnormalities | Syndactyly | 0.3430264696222015 |
Drug-Induced Abnormalities | Synostosis | 0.38355214601147614 |
Drug-Induced Abnormalities | Congenital Syphilis | 0.22612546428933034 |
Drug-Induced Abnormalities | Tangier Disease | 0.09245500931811057 |
Drug-Induced Abnormalities | Tay-Sachs Disease | 0.033794500669876215 |
Drug-Induced Abnormalities | Hereditary Hemorrhagic Telangiectasia | 0.3430264696222015 |
Drug-Induced Abnormalities | Androgen-Insensitivity Syndrome | 0.310198271667516 |
Drug-Induced Abnormalities | Tetralogy of Fallot | 0.3430264696222015 |
Drug-Induced Abnormalities | Thalassemia | 0.18766904849475052 |
Drug-Induced Abnormalities | Thanatophoric Dysplasia | 0.3430264696222015 |
Drug-Induced Abnormalities | Thrombasthenia | 0.18766904849475052 |
Drug-Induced Abnormalities | Tooth Abnormalities | 0.38355214601147614 |
Drug-Induced Abnormalities | Supernumerary Tooth | 0.3430264696222015 |
Drug-Induced Abnormalities | Congenital Toxoplasmosis | 0.22612546428933034 |
Drug-Induced Abnormalities | Tracheobronchomegaly | 0.38355214601147614 |
Drug-Induced Abnormalities | Transposition of Great Vessels | 0.3430264696222015 |
Drug-Induced Abnormalities | Trilogy of Fallot | 0.3430264696222015 |
Drug-Induced Abnormalities | Persistent Truncus Arteriosus | 0.28232930875488305 |
Drug-Induced Abnormalities | Tuberous Sclerosis | 0.310198271667516 |
Drug-Induced Abnormalities | Turner Syndrome | 0.3430264696222015 |
Drug-Induced Abnormalities | Conjoined Twins | 0.38355214601147614 |
Drug-Induced Abnormalities | Urogenital Abnormalities | 0.4373356273919856 |
Drug-Induced Abnormalities | Velopharyngeal Insufficiency | 0.3430264696222015 |
Drug-Induced Abnormalities | von Willebrand Diseases | 0.18766904849475052 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.